CHICAGO, Feb. 7 /PRNewswire-FirstCall/ -- The Female Health Company today announced that it will host an investor conference call to discuss its operating results for the first quarter of FY2007. The Company plans to report its operating results on Wednesday, February 14, 2007 and an investor conference call has been scheduled for 11:00 a.m. Eastern Standard Time the same day.
Shareholders and other interested parties may participate in the conference call by dialing 866-406-5408 (international callers dial 973-582-2770) and referencing the conference ID 8331284, a few minutes before 11:00 a.m. EST on February 14, 2007. A replay of the call will be available through February 21, 2007 by dialing 877-519-4471 (international callers dial 973-341-3080) and entering the conference ID 8331284.
The Company requests that shareholders and other interested parties pre-submit questions for the conference call by emailing such questions to the Company at FHCInvestor@femalehealthcompany.com.
About the Female Health Company, Inc.
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC Female Condom(R), which is primarily distributed by public health organizations and donor groups in over 90 developing countries around the world. World-wide, the Female Condom is available in various programs in 108 countries. The Company owns certain worldwide rights to the FC Female Condom(R), including patents that have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, the European Patent Convention, the People’s Republic of China, Canada, South Korea and Australia. FC Female Condom(R) is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.
“Safe Harbor” statement under the Private Securities Litigation Reform Action of 1995: The statements in this release which are not historical fact are forward-looking statements based upon the Company’s current plan and strategies, and reflect the Company’s current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company’s press releases, shareholder communication and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company’s operations may vary from those currently anticipated.
For more information about the Female Health Company visit the Company’s website at http://www.femalehealth.com and http://www.femalecondom.org . If you would like to be added to the Company’s e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com .
Contacts: William R. Gargiulo, Jr. 231.526.1244 Donna Felch 312.595.9742
Female Health Company
CONTACT: William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch,+1-312-595-9742, both for Female Health Company
Web site: http://www.femalehealth.com//
